RedcapTour Co., Ltd. (KOSDAQ:038390)
South Korea · Delayed Price · Currency is KRW 10,430
-120 (-1.14%)
At close: Apr 13, 2026
RedcapTour Revenue
In the year 2025, RedcapTour had annual revenue of 365.55B KRW with 1.86% growth. RedcapTour had revenue of 76.60B in the quarter ending December 31, 2025, a decrease of -16.08%.
Revenue
365.55B
Revenue Growth
+1.86%
P/S Ratio
0.48
Revenue / Employee
1.07B
Employees
343
Market Cap
174.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.55B | 6.68B | 1.86% |
| Dec 31, 2024 | 358.88B | 20.69B | 6.12% |
| Dec 31, 2023 | 338.18B | 76.12B | 29.05% |
| Dec 31, 2022 | 262.06B | 33.13B | 14.47% |
| Dec 31, 2021 | 228.93B | -556.76M | -0.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Powerlogics | 686.53B |
| Macrogen | 195.27B |
| IL CO.,LTD. | 102.86B |
| Namu Tech | 102.27B |
| OPTUS Pharmaceutical | 87.16B |
| Chemtros | 56.81B |
| Solux | 38.27B |
| GC Genome | 31.53B |